CASI PHARMACEUTICALS INC - COM (CASI)

CUSIP: 14757U109

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM
Total 13F shares
41,424,694
Share change
+1,829,309
Total reported value
$122,202,721
Price per share
$2.95
Number of holders
68
Value change
+$5,597,299
Number of buys
38
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP 14757U109?
CUSIP 14757U109 identifies CASI - CASI PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CASI PHARMACEUTICALS INC - COM (CASI) as of Q4 2020

As of 31 Dec 2020, CASI PHARMACEUTICALS INC - COM (CASI) was held by 68 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 41,424,694 shares. The largest 10 holders included IDG-Accel China Growth Fund III Associates L.P., Consonance Capital Management LP, FEDERATED HERMES, INC., BlackRock Inc., VANGUARD GROUP INC, Wellington Shields Capital Management, LLC, Wellington Shields & Co., LLC, Ikarian Capital, LLC, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 68 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.